AMGEN WINS PATENT APPEAL ON OTEZLA® (APREMILAST)

Appeals Court Affirms Validity of Patent Expiring in 2028 THOUSAND OAKS, Calif., April 19, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.